TriSalus CEO Szela surrenders 2,693 shares
TriSalus Life Sciences CEO Szela Mary T surrendered 2,693 shares at $4.38 per share, for $11,795, reported on Form 4.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
TriSalus Life Sciences CEO Szela Mary T surrendered 2,693 shares at $4.38 per share, for $11,795, reported on Form 4.